Skip to main content

The 2024 Innovations in Dermatological Sciences Conference will be held remotely on September 24, 2024!

 

Our Plenary Speakers for the event will be:

“The 2024 Dermatology Market: The Good, The Bad and The Ugly” 

Presented by:

Dr. Seth Orlow
New York University/Pharus Advisors

 

 

 

“Non-surgical skin cancer treatment using bioadhesive nanoparticles”

Presented by:

Dr. Michael Girardi, MD
Department of Dermatology, Yale School of Medicine

and

 

 

Dr. W. Mark Saltzman
Department of Biomedical Engineering, Yale University

 

 

 

The 2024 conference format has been updated to contain two intensive parallel tracks during the afternoon sessions.  Attendees can select which presentations they would like to attend and will have access to the presentations not viewed for 60 days post conference.

 

Track 1: Skin Biology & the Science of Topicals
Track 2: Dermatological & Cosmeceutical Product Development

 

Track 1:  Skin Biology & the Science of Topicals

“Light-based Beauty Tech, the next frontier in skin rejuvenation”
presented by Dr. Lieve Declercq, Skin-DLite (bv)

“Topical Drug R&D using Open-Flow Microperfusion: Insights into Skin Biology”
presented by Dr. Manfred Bodenlenz, JOANNEUM RESEARCH HEALTH- Institute for Biomedical Research and Technologies

Title TBA; Topic: MALDI
presented by Dr. Jean-Philippe Therrien, JP Therrien Consulting LLC

“Solving formulation challenges: solubility & drug targeting”
presented by Dr. Bozena Michniak-Kohn, Rutgers University, Center for Dermal Research and Ernest Mario School of Pharmacy

“Troubleshooting and trouble avoiding for topical semi-solid formulations”
presented by Dr. Michael Herbig, RaDes GmbH

“AI Image Analytics for Topicals: Implications for Drug Delivery and Q3 Microstructure Equivalence”
presented by Joshua Lomeo, Director of Application Science, digiM solution

 

Track 2: Dermatological & Cosmeceutical Product Development 

Titles to be posted shortly

Topic:  Simulated Software and selecting the right excipients by Mark Chandler, ACT Solutions

Topic:  Niasomes/flexible liposomes by Dr. Rafael Chachi, Naturalis

Topic:  AI approaches in reducing the pre-formulation efforts (drug-excipient interactions) by Dr. Ravi Shekar Ananthula, PharmaDEM Solutions Pvt Ltd

Topic: Tools in understanding microstructure and the dependencies of manufacturing and formulation parameters, by Dr. Abu Badruddoza, Pfizer

Topic:  Innovative packaging devices for topical formulations by a representative from Aptar